| 000 | 00617 a2200205 4500 | ||
|---|---|---|---|
| 005 | 20151026133047.0 | ||
| 008 | 120627t xxu||||| |||| 00| 0 eng d | ||
| 080 |
_a575.111:615 _bMIS |
||
| 100 |
_aMisra, Ambikanandan; ed. _eed.by _920744 |
||
| 245 | _aChallenges in delivery of therapeutic genomics and proteomics | ||
| 300 | _axiv, 671p. | ||
| 490 | _aElesevier insights series | ||
| 653 | _aPharmaceutical biotechnology | ||
| 653 | _aGeomics-gene therapy | ||
| 653 | _aProtein drugs | ||
| 653 | _aProteomics | ||
| 942 | _cBK | ||
| 260 |
_bElsevier _c2011 _aMassachusetts _920745 |
||
| 020 | _a9780123849649 | ||
| 999 |
_c62411 _d62411 |
||